FERVAY-500?
Product Description
Biocon Limited
-
IN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
Categories
Specifications
Biocon Limited
-
IN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
More Products from Biocon Limited (99)
-
Product ENTAVAR? Tablet
Biocon offers a wide range of comprehensive care which includes entavar tablet. Composition: each film coated tablet contains linezolid - 600mg composition. Mechanism of action: linezolid is a synthetic antibacterial agent of a new class of antibiotics, the oxazolidinones, which has clinical utility in the... -
Product ERYPRO Prefil?
Biocon offers a wide range of nephrology which includes erypro prefil?. Composition: each 1ml prefilled syringe of erypro prefil 2000 contains: recombinant human erythropoietin alfa: 2000 iu/ml, each 1ml prefilled syringe of erypro prefil 4000 contains: recombinant human erythropoietin alfa: 4000 iu/ml. Me... -
Product ERYPRO safe?
Biocon offers a wide range of nephrology which includes erypro safe. Composition: each pre-filled syringe contains: recombinant human erythropoietin alpha: 2000iu/1.0 ml - 10000iu/1.0 ml. Indications: it is indicated for the treatment of anaemia associated with chronic renal failure (crf) including patient... -
Product ERYPRO?
Biocon offers a wide range of nephrology which includes erypro. Composition: each 1ml vial of erypro 2000 contains: recombinant human erythropoietin alfa: 2000 iu/ml, each 1ml vial of erypro 4000 contains: recombinant human erythropoietin alfa: 4000 iu/ml, each 1ml vial of erypro 10000 contains: recombinan... -
Product EVERTOR? 5/10mg
Biocon offers a wide range of oncotherapeutic which includes evertor? 5/10mg. Composition: each 5mg evertor? tablet contains 5mg everolimus, each 10mg evertor? tablet contains 10mg everolimus. Mechanism of action: everolimus is a selective mtor (mammalian target of rapamycin) inhibitor. Mtor is a key serin... -
Product FERVAY-250?
Biocon offers a wide range of comprehensive care which includes fervay-250?. Composition: each film coated tablet contains: cefuroxime axetil ip, equivalent to cefuroxime 250 mg. Mechanism of action: cefuroxime inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding prote... -
Product FERVAY? 1.5 g
Biocon offers a wide range of comprehensive care which includes fervay 1.5 g. Composition: each vial contains: sterile cefuroxime sodium ip, eq. To cefuroxime 1.5 g. Mechanism of action: cefuroxime inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (pbp?s). ... -
Product FERVAY? 750 mg
Biocon offers a wide range of comprehensive care which includes fervay 750 mg. Composition: each vial contains: sterile cefuroxime sodium ip, eq. To cefuroxime 750 mg. Mechanism of action: cefuroxime inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (pbp?s)... -
Product FEVEIN?
Biocon offers a wide range of nephrology which includes fevein. Composition: each 5 ml ampoule contains: ferric hydroxide in complex with sucrose equivalent to elemental iron 100 mg, water for injection ip q. S. Mechanism of action: following intravenous (iv) administration, iron sucrose is dissociated int... -
Product FOSAPORT?
Biocon offers a wide range of oncotherapeutic which includes fosaport. Mechanism of action: it is a prodrug of aprepitant and accordingly, its antiemetic effects are attributable to aprepitant. Aprepitant is a selective high-affinity antagonist of human substance p/neurokinin 1 (nk1) receptors. Aprepitant ... -
Product GABIL?
Biocon offers a wide range of metabolic which includes gabil. Composition: gabapentin 300mg + methylcobalamin 500mcg tablets. Mechanism of action: gabapentin: action is potentially via binding to the alpha 2 delta sub units of voltage gated calcium channels and inhibition of glutamide release presynaptical... -
Product Genxtor?
Biocon offers a wide range of oncotherapeutic which includes genxtor?temsirolimus, an inhibitor of mtor, is an antineoplastic agent. Temsirolimus is a prescription medicine used to treat people with advanced kidney cancer (renal cell carcinoma or rcc) who have at least three of six prognostic risk factors....
Biocon Limited resources (1)
-
News Viatris and Biocon score historic first for interchangeable biosimilar product
The new approval of Semeglee allows pharmacy-level substitution for Lantus across the US
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance